What is immunotherapy?
Ask the doctor
About 20 years ago, two scientists — one in the United States and one in Japan — were studying T cells, immune system cells that attack foreign things. They weren't studying cancer. They were just trying to figure out how T cells work. Each of the scientists found a chemical on the surface of T cells that had not previously been discovered. One chemical was called PD-1, and the other CTLA-4. What did they do? When stimulated, the chemicals kept the T cells from attacking things: they applied the brakes.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online Plus (HHO+) to unlock expert-backed health insights, personalized tools, and exclusive resources to feel your best every day.
Here’s what you get with your HHO+ membership:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
I’d like to subscribe to HHO+ for $4.99/month to access expert-backed content to help make smart, informed decisions about my well-being.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
